Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 129

    1.

    Molecular mechanisms in Behçet's disease.

    Rajendram R, Rao NA.

    Br J Ophthalmol. 2003 Oct;87(10):1199-200. No abstract available. PMID: 14507744 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Abnormal expression of chemokine receptors in Behçet's disease: relationship to intracellular Th1/Th2 cytokines and to clinical manifestations.

    Houman H, Hamzaoui A, Ben Ghorbal I, Khanfir M, Feki M, Hamzaoui K.

    J Autoimmun. 2004 Nov;23(3):267-73.PMID: 15501397 [PubMed - indexed for MEDLINE]Related articles

    3.

    Correlation between mRNA expression of Th1/Th2 cytokines and their specific transcription factors in human helper T-cell clones.

    Kitamura N, Kaminuma O, Mori A, Hashimoto T, Kitamura F, Miyagishi M, Taira K, Miyatake S.

    Immunol Cell Biol. 2005 Oct;83(5):536-41.PMID: 16174104 [PubMed - indexed for MEDLINE]Related articles

    4.

    Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus.

    Lit LC, Wong CK, Li EK, Tam LS, Lam CW, Lo YM.

    J Rheumatol. 2007 Jan;34(1):89-96. Epub 2006 Nov 15.PMID: 17117487 [PubMed - indexed for MEDLINE]Related articles

    5.

    Immunophenotype and Th1/Th2 cytokines in patients with Adamantiades-Behçet's disease.

    Psarra K, Kapsimali V, Vaiopoulos G, Nikolopoulou M, Kaklamanis P, Palimeris G, Kaklamani E, Papasteriades C.

    Adv Exp Med Biol. 2003;528:249-53. No abstract available. PMID: 12918701 [PubMed - indexed for MEDLINE]Related articles

    6.

    [Production of Th1/Th2 cytokines and nitric oxide in Behçet's uveitis and idiopathic uveitis]

    Guenane H, Hartani D, Chachoua L, Lahlou-Boukoffa OS, Mazari F, Touil-Boukoffa C.

    J Fr Ophtalmol. 2006 Feb;29(2):146-52. French. PMID: 16523155 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Behçet's disease: an update on the pathogenesis.

    Gül A.

    Clin Exp Rheumatol. 2001 Sep-Oct;19(5 Suppl 24):S6-12.PMID: 11760403 [PubMed - indexed for MEDLINE]Related articles

    8.

    Role of IL-12B promoter polymorphism in Adamantiades-Behcet's disease susceptibility: An involvement of Th1 immunoreactivity against Streptococcus Sanguinis antigen.

    Yanagihori H, Oyama N, Nakamura K, Mizuki N, Oguma K, Kaneko F.

    J Invest Dermatol. 2006 Jul;126(7):1534-40. Epub 2006 Mar 2.PMID: 16514412 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Cytokine expression within mucocutaneous lesions of Behçet's disease: involvement of proinflammatory and Th1 cytokines.

    Ben Ahmed M, Houman H, Ben Ghorbel I, Braham-Sfaxi A, Miled M, Dellagi K, Louzir H.

    Adv Exp Med Biol. 2003;528:343-6. No abstract available. PMID: 12918721 [PubMed - indexed for MEDLINE]Related articles

    10.

    Chronic morphine treatment differentiates T helper cells to Th2 effector cells by modulating transcription factors GATA 3 and T-bet.

    Roy S, Wang J, Gupta S, Charboneau R, Loh HH, Barke RA.

    J Neuroimmunol. 2004 Feb;147(1-2):78-81.PMID: 14741432 [PubMed - indexed for MEDLINE]Related articles

    11.

    Blimp-1 attenuates Th1 differentiation by repression of ifng, tbx21, and bcl6 gene expression.

    Cimmino L, Martins GA, Liao J, Magnusdottir E, Grunig G, Perez RK, Calame KL.

    J Immunol. 2008 Aug 15;181(4):2338-47.PMID: 18684923 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Behçet's disease.

    Hirohata S, Kikuchi H.

    Arthritis Res Ther. 2003;5(3):139-46. Epub 2003 Apr 2. Review.PMID: 12723980 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    T-bet/GATA-3 ratio is a surrogate measure of Th1/Th2 cytokine profiles and may be novel targets for CpG ODN treatment in asthma patients.

    Dong L, Chen M, Zhang Q, Li LZ, Xu XQ, Xiao W.

    Chin Med J (Engl). 2006 Aug 20;119(16):1396-9. No abstract available. PMID: 16934187 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Serum soluble CD30 levels in Behçet's disease.

    Düzgün N, Ayaslioglu E, Tutkak H.

    Clin Exp Rheumatol. 2004 Jul-Aug;22(4 Suppl 34):S17-20.PMID: 15515777 [PubMed - indexed for MEDLINE]Related articles

    16.

    T-bet expression is upregulated in active Behçet's disease.

    Li B, Yang P, Zhou H, Zhang Z, Xie C, Lin X, Huang X, Kijlstra A.

    Br J Ophthalmol. 2003 Oct;87(10):1264-7.PMID: 14507763 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Increased risk of human leukocyte antigen-G gene variants in Behçet's disease.

    Park KS, Nam JH, Lee ES, Choi JS, Bang D, Lee S.

    Clin Exp Rheumatol. 2006 Sep-Oct;24(5 Suppl 42):S126-7. No abstract available. Erratum in: Clin Exp Rheumatol. 2007 May-Jun;25(3):507-8. PMID: 17067446 [PubMed - indexed for MEDLINE]Related articles

    18.

    Regulatory networks induced by live parasites impair both Th1 and Th2 pathways in patent lymphatic filariasis: implications for parasite persistence.

    Babu S, Blauvelt CP, Kumaraswami V, Nutman TB.

    J Immunol. 2006 Mar 1;176(5):3248-56.PMID: 16493086 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Immunopathogenesis of Behçet's disease.

    Lehner T.

    Ann Med Interne (Paris). 1999 Oct;150(6):483-7. Review.PMID: 10615534 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data